CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide

Journal of Immunology

Volumn 168, Issue 3, 2002, Pages 1212-1218

  Miconnet, Isabelle ^a   Koenig, Sylvain ^a   Speiser, Daniel ^a   Krieg, Arthur ^a   Guillaume, Philippe ^a   Cerottini, Jean Charles ^a   Romero, Pedro ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT; IMMUNOLOGICAL ADJUVANT; OLIGODEOXYNUCLEOTIDE; TUMOR ANTIGEN; TUMOR VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CONTROLLED STUDY; CPG ISLAND; CYTOTOXIC T LYMPHOCYTE; DRUG MECHANISM; IMMUNE RESPONSE; IMMUNOSTIMULATION; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0036467426     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.3.1212     Document Type: Article

References (43)

1. Dendritic cell vaccines for cancer immunotherapy
2. Dendritic cells: On the move from bench to bedside
3. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
4. Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction
5. Coley's toxins, tumor necrosis factor and cancer research: A historical perspective
6. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. 1. Isolation, physicochemical characterization, and antitumor activity
7. CpG motifs in bacterial DNA trigger direct B-cell activation
8. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells
9. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA
10. CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells
11. Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins
12. CpG-DNA activates in vivo T cell epitope-presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses
13. Oligonucleotide adjuvants for T helper 1 (Th1)specific vaccination
14. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen
15. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants
16. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity
17. CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines
18. Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with antitumor activity
19. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
20. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes
21. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogs
22. *0201/Kb transgenic mice
23. 2m double knockout mice
24. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes
25. 3 domain of class I influence the magnitude of the xenogeneic response
26. Phenotypic analysis of antigen-specific T lymphocytes
27. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: Definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes
28. Serological analysis of Melan-A(MART-1), a melanocytespecific protein homogeneously expressed in human melanomas
29. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes
30. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers
31. Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100
32. Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis
33. CpG-DNA-mediated transient lymphadenopathy is associated with a state of Th1 predisposition to antigen-driven responses
34. DNA as an adjuvant: Capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen
35. + T cell differentiation: Initial antigen encounter triggers a developmental program in naive cells
36. CpGoligodeoxynucleotides co-stimulate primary T cells in the absence of antigenpresenting cells
37. Oligodeoxynucleotides containing palindrome sequences with internal 5′-CpG-3′ act directly on human NK and activated T cells to induce 1FN-γ production in vitro
38. APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class 1-restricted T cells
39. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
40. + T-helper and a T-killer cell
41. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
42. + dendritic cells
43. A toll-like receptor recognizes bacterial DNA